Search
for
Sort by
Research 301–330 of 323
- Alopecia Areata Incognita: Current Evidence
- Advances in Topical Therapies for Clinically Relevant and Prevalent Forms of Alopecia
- Circumscribed Alopecia Areata Incognita and Response to Tofacitinib
- Non-Scarring Alopecia in Females: A Comprehensive Review
- Diphenylcyclopropenone in severe alopecia areata in children and adolescents: long-term follow-up and relapse rate
- Characteristics and Management of Patients with Alopecia Areata and Selected Comorbid Conditions: Results from a Survey in Five European Countries
- A diagnostic clue: New onset alopecia sparing white hairs
- Treatment preferences of adults and adolescents with alopecia areata: A discrete choice experiment
- Degree of Alignment Between Japanese Patients and Physicians on Alopecia Areata Disease Severity and Treatment Satisfaction: A Real-World Survey
- Targetoid Hair Regrowth Pattern in Alopecia Areata: A Case Series
- Diagnosis and Management of Alopecia Areata: A Saudi Expert Consensus Statement (2023)
- An Updated in the Management of Alopecia Areata
- Review on Alopecia Areata in the Middle East and Africa: Landscape and Unmet Needs
- Overview of alopecia areata for managed care and payer stakeholders in the United States
- Alopecia areata
- Efficacy and Safety of Platelet-Rich Plasma Therapy in Alopecia Areata Patients: A Systematic Review
- Alopecia areata: a review of diagnosis, pathogenesis and the therapeutic landscape
- Tratamiento de la alopecia areata, un recorrido desde las opciones terapéuticas clásicas hasta los nuevos fármacos aparecidos en los últimos años
- Oral Presentations
- Alopecia Areata: Current Review
- Successful management of severe alopecia areata and vitiligo using topical delgocitinib and a 308-nm excimer laser
- Auditory Threshold Variability in the SAMP8 Mouse Model of Age-Related Hearing Loss: Functional Loss and Phenotypic Change Precede Outer Hair Cell Loss
- Adverse events of the thyroid peroxidase inhibitor methimazole in the treatment of hyperthyroidism: a comprehensive analysis from the first quarter of 2004 to the first quarter of 2025
- Treatment of Alopecia Areata With Squaric Acid Dibutylester
- Treatment of alopecia areata with squaric acid dibutylester
- Discoid lupus erythematosus exacerbated by contact dermatitis caused by use of squaric acid dibutylester for topical immunotherapy in a patient with alopecia areata
- Childhood epidermolysis bullosa acquisita during squaric acid dibutyl ester immunotherapy for alopecia areata
- Angioedema After Squaric Acid Treatment in a 6‐Year‐Old Girl
- Topical use of calcipotriol does not potentiate squaric acid dibutylester effectiveness in the treatment of alopecia areata
- Hapten‐induced lymphadenosis benigna cutis secondary to squaric acid dibutylester sensitization for alopecia areata